For the WHO, women are disadvantaged compared to men with regard to their health.
There is no respect for gender differences is not taken into account that belong to one sex over another affects the health and perception of health. The clinical trials are conducted without taking into account the physiological differences between men and women. The topics chosen, the methods used and the subsequent analysis of the data reflect a male perspective.
Yet according to ISTAT data, women are consumers of drugs than men (42.1% vs. 32.3) and adverse reactions are more common in women (1, 5-1, 7 compared to males).
The women’s disorders require attention
E ‘should devote more space to information relating not only to diseases and conditions of women (for example, breast cancer, menopause), but also to those diseases which are most likely to affect women, such as osteoporosis, arthritis or depression. Already in study of family doctors and specialists, the patients are women in the majority.